Mural Oncology plc
MURA
Get informed when a big investor buys or sells
+ FollowMarket Cap$35.38M
Close$
$6.34
210.6% upside
Current Fair Value
210.6% upsideUndervalued by 210.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $35.38 Million |
|---|---|
| Enterprise Value | $-19,941,249.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.58 |
| Beta | 2.97 |
| Outstanding Shares | 17,321,544 |
Return
| Return on Equity | -215.81% |
|---|---|
| Return on Assets | -181.12% |
| Return on Invested Capital | -64.92% |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | 0.34 |
| Price to Sales | - |
| Price to Book Ratio | 0.68 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.56 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.18 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 6, 2025
EPS Estimate
$-0.59
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1119▼ 436.14% |
|---|---|
| Total Calls | 748,600▲ 424.23% |
| Total Puts | 83,800▼ 86.88% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 30.81%▼ 16.86% |
|---|---|
| Total Invested | $11.01M▼ 45.84% |
| Investors Holding | 61▼ 6.00% |
ESG Score
No data